Using cold application to reduce pain during chest tube removal in young children
Investigation of the Effect of Cold Application on Patient's Pain and Vital Signs During Chest Tube Removal.
This study tests if using cold packs can help reduce pain for infants and young children when their chest tubes are taken out.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 1 Month to 3 Years |
| Sex | All |
| Sponsor | Muğla Sıtkı Koçman University Academic / other |
| Locations | 1 site (Fethiye, Muğla) |
| Trial ID | NCT05046834 on ClinicalTrials.gov |
What this trial studies
This study examines the effects of cold application on pain levels and vital signs in infants and children aged 0-3 years during and after chest tube removal. It employs a randomized controlled, prospective, and cross-sectional design to assess pain scores and physiological responses. The research will involve applying cold treatment 15 minutes prior to the procedure and monitoring outcomes using established pain scales and vital sign assessments.
Who should consider this trial
Good fit: Ideal candidates for this study are infants and children aged 0-3 years who have had a chest tube in place for at least 24 hours and are stable cardiovascularly.
Not a fit: Patients with neurological, nephrological, or respiratory diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce pain and discomfort for young patients undergoing chest tube removal.
How similar studies have performed: While the specific application of cold treatment in this context may be novel, similar studies have shown that cold applications can effectively reduce pain in various medical procedures.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between the ages of 0-3 years old, * The chest tube is located for at least 24 hours, * Without Mechanical ventilation support, * Does not have any allergies to the drug * Stable from the cardiovascular side Exclusion Criteria: * Children with any neurological diseases, * Children with anynephrological * Children with any respiratory diseases
Where this trial is running
Fethiye, Muğla
- Gonca Muslu — Fethiye, Muğla, Turkey (Recruiting)
Study contacts
- Principal investigator: gonca muslu — Muğla Sıtkı Koçman University
- Study coordinator: GONCA MUSLU, PhD
- Email: goncamuslu@mu.edu.tr
- Phone: 9050539959224
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.